This session will present issues unique to the chemical and biotech arts in medical technology. Specifically, the session will include case studies and practical suggestions for overcoming subject matter eligibility, enablement, and written description issues. Other topics to be discussed will include case law on the obviousness of medical technology patents. This session will NOT cover inventions relating solely to pharmaceutical products.